H.Res. 484 · 117th Congress

Expressing the sense of the House of Representatives that the United States should not waive intellectual property rights relating to COVID-19 vaccines or treatments.

Stage
In committee
Sponsor
Mariannette Miller-Meeks
Introduced
2021-06-17
Latest action
2022-11-01 · Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.

Action history

  1. 2022-11-01Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
  2. 2021-06-17Introduced in House
  3. 2021-06-17Referred to the House Committee on the Judiciary.